Main

Voice signal analysis was done on a large group of patients with chronic health conditions registered to a telemedicine call center at Sheba Medical Center.

While millions of people worldwide are battling against COVID-19, fortunately, the vast majority of patients who get infected will overcome the disease and survive.

On April 1, the first patient who recovered from Covid-19 donated plasma at the Magen David Adom (MDA) Blood Services Center at Sheba Medical Center.

Introducing Sheba's Critical Care Corona Unit The head of Sheba Medical Center's Infectious Disease unit, Professor Gili Regev-Yochay, speaks with Steve Walz, our international spokesperson, about Sheba's new Critical Care Corona Unit (CCCU) underground complex.

A compact blood analyzer developed by an Israeli blood testing startup has been implemented to support the healthcare management of coronavirus-infected patients.

Approximately two months after coronavirus COVID-19 broke out in China, the country has almost succeeded in halting the epidemic.

Sheba Medical Center pushes forward with digital healthcare, embracing telemedicine to monitor patients in quarantine and treat patients with coronavirus COVID-19 remotely.

Proactive, detailed planning helped Sheba to confront the different hurdles involved in dealing with coronavirus. “We had a full drill a month before the first coronavirus patient was diagnosed in Israel,” Walz said.

Lung cancer is the type of cancer that leads to the highest mortality rate in men and the third highest in women.